Cluster Health & Mission Cancer Brokerage Event

28 Sept 2026 | Brussels, Belgium

Register
Register
Register

State Research Institute Centre for Innovative Medicine

Other

www.imcentras.lt/en/Vilnius, Lithuania
1 profile visit

About

State Research Institute Centre for Innovative Medicine is a public research organisation conducting long-term biomedical research and experimental development of strategic importance to national healthcare, society and international collaboration.

The mission of the Centre is to ensure scientific excellence and deliver high-level biomedical research addressing key challenges in healthcare and societal development.

The institute carries out advanced research and innovation activities, collaborates with industry, public sector and academic partners, and provides scientific, methodological and technological support to healthcare and research institutions.

It also actively contributes to the dissemination of scientific knowledge and its application in healthcare, fostering innovation-driven development and a knowledge-based society.

The Centre is actively seeking international partnerships for joint research and innovation projects.

Representatives

General manager

State Research Institute Centre for Innovative Medicine

Marketplace (1)

  • Project cooperation

    The Centre for Innovative Medicine (IMC)

    The Centre for Innovative Medicine (IMC) is a state research institute in Vilnius, Lithuania, conducting multidisciplinary biomedical research focused on translating scientific discoveries into innovative medical solutions.

    • Partner seeks Consortium/Coordinator
    • Consortium/Coordinator seeks Partners
    • Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
    • Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
    • Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
    • Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
    • Healthcare innovations: HORIZON-MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
    Author

    General manager at State Research Institute Centre for Innovative Medicine

    Vilnius, Lithuania